0 companies available
↑ ↓ to navigate Enter to select Esc to close
AMGEN INC
AMGN
Biological Products No Disgnostic Substances Last filing · Quarter 2 · Jun 30, 2026Export XLSX
| Ratios | LTM | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Margin | 69.52% | 67.25% | 61.53% | 70.02% | ||||||||||||||
Operating Margin | 29.99% | 24.71% | 21.71% | 28.01% | ||||||||||||||
Pretax Margin | 27.00% | 24.42% | 13.79% | 27.86% | ||||||||||||||
Effective Tax Rate | 15.01% | 14.09% | 11.26% | 14.49% | ||||||||||||||
Net Margin | 22.95% | 20.98% | 12.24% | 23.83% | ||||||||||||||
Current Ratio | - | 1.14x | 1.26x | 1.65x | ||||||||||||||
Debt to Equity | - | 9.46x | 14.63x | 14.59x | ||||||||||||||
Net Debt to Equity | - | 8.41x | 12.59x | 12.83x | ||||||||||||||
Asset Turnover | - | 40.57% | 36.39% | 29.02% | ||||||||||||||
Return on Equity | - | 89.06% | 69.59% | 107.78% | ||||||||||||||
Return on Assets | - | 8.51% | 4.45% | 6.91% |